World's Best Scientists 2026 revealed!
Timo Vesikari

Timo Vesikari

D-Index & Metrics

Immunology

D-Index
89
Citations
35812
World Ranking
1103
National Ranking
7

Medicine

D-Index
89
Citations
35934
World Ranking
12524
National Ranking
140

Overview

Timo Vesikari is affiliated with Tampere University in Finland and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research encompasses a variety of topics primarily centered on bacterial infections, vaccines, and respiratory infections. The scientist's work also covers influenza virus research, viral gastroenteritis, viral immunology, and congenital diaphragmatic hernia studies.

Their research output includes numerous publications in high-impact journals, reflecting a focus on clinical immunogenicity, vaccine safety, and infectious disease epidemiology. The principal venues for their work include Human Vaccines & Immunotherapeutics, Vaccine, The Journal of Infectious Diseases, The Lancet Infectious Diseases, and Diabetes.

  • Recent papers:
  • Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study, 2020, Human Vaccines & Immunotherapeutics
  • Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings, 2022, The Journal of Infectious Diseases
  • Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study, 2022, Vaccine
  • Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age, 2020, Human Vaccines & Immunotherapeutics
  • Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months, 2021, Vaccine

The main fields of study addressed by their publications include Medicine, with 21 works, and Immunology and Microbiology, represented in 6 publications. More specialized subfields of their research include Epidemiology (14 publications), Microbiology (6), Infectious Diseases (2), Cardiology and Cardiovascular Medicine (2), and Surgery (1).

The main research topics featured in their work are:

  • Bacterial Infections and Vaccines
  • Pneumonia and Respiratory Infections
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • Viral Infections and Immunology Research
  • Congenital Diaphragmatic Hernia Studies

Frequent collaborators in their research include John L. Perez with four shared publications, and others such as Aino Forstén, Joanne M. Langley, Chris Webber, and Marie Van der Wielen, each with two collaborations.

Best Publications

  • Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

    Guillermo M. Ruiz-Palacios;Irene Pérez-Schael;F. Raúl Velázquez;Hector Abate

  • Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine

    Timo Vesikari;David O Matson;Penelope Dennehy;Pierre Van Damme

  • Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

    Himal Lal;Anthony L. Cunningham;Olivier Godeaux;Roman Chlibek

  • Live attenuated versus inactivated influenza vaccine in infants and young children.

    Robert B. Belshe;Kathryn M. Edwards;Timo Vesikari;Steven V. Black

  • Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

    A. L. Cunningham;H. Lal;M. Kovac;R. Chlibek

  • Lactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis

    Heli Majamaa;Erika Isolauri;Maija Saxelin;Timo Vesikari

  • Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children.

    Aino-Vieno Shornikova;Ivan A. Casas;Erika Isolauri;Hannu Mykkänen

  • Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50–59 Years

    Kenneth E. Schmader;Myron J. Levin;John W. Gnann;John W. Gnann;Shelly A. McNeil

  • Burden of rotavirus disease in European Union countries.

    Montse Soriano-Gabarró;Jacek Mrukowicz;Timo Vesikari;Thomas Verstraeten

  • Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG

    Erika Isolauri;Jaana Joensuu;Hanna Suomalainen;Mari Luomala

  • PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINE

    Timo Vesikari;Erika Isolauri;Eric D'Hondt;Andrée Delem

  • Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

    Steven Black;Uwe Nicolay;Timo Vesikari;Markus Knuf

  • Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis.

    Aino-Vieno Shornikova;Ivan A. Casas;Hannu Mykkänen;Eeva Salo

  • Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children

    Timo Vesikari;Markus Knuf;Peter Wutzler;Aino Karvonen

  • Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis

    Jaana Joensuu;Eeva Koskenniemi;Xiao-Li Pang;Timo Vesikari

  • Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea.

    M Kaila;E Isolauri;M Saxelin;H Arvilommi

  • Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

    Timo Vesikari;Susanna Esposito;Roman Prymula;Ellen Ypma

  • Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

    Timo Vesikari;Jacek Wysocki;Bertrand Chevallier;Aino Karvonen

  • Human caliciviruses in acute gastroenteritis of young children in the community.

    Xiao-Li Pang;Shinjiro Honma;Shuji Nakata;Timo Vesikari

  • Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants

    Timo Vesikari;Aino Karvonen;Leena Puustinen;Shang-Qin Zeng

  • Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.

    Timo Vesikari;Michele Pellegrini;Aino Karvonen;Nicola Groth

  • Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland

    Maria Hemming;Sirpa Räsänen;Leena Huhti;Minna Paloniemi

  • One-step quantitative RT-PCR for the detection of rotavirus in acute gastroenteritis.

    S.-Q. Zeng;A. Halkosalo;M. Salminen;E.D. Szakal

  • A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea

    A V Shornikova;E Isolauri;L Burkanova;S Lukovnikova

Frequent Co-Authors

Markku Mäki
Markku Mäki Tampere University
Albert Z. Kapikian
Albert Z. Kapikian National Institutes of Health
Erika Isolauri
Erika Isolauri University of Turku
Myron J. Levin
Myron J. Levin University of Colorado Anschutz Medical Campus
Janet E. McElhaney
Janet E. McElhaney Health Sciences North
Heikki Hyöty
Heikki Hyöty Tampere University
Carlo Giaquinto
Carlo Giaquinto University of Padua
Anthony L. Cunningham
Anthony L. Cunningham University of Sydney
Shelly A. McNeil
Shelly A. McNeil Dalhousie University
Max Ciarlet
Max Ciarlet Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, exploring related healthcare degrees can broaden career opportunities. Many turn to nursing pathways, which complement immunological knowledge with practical patient care skills. Programs like the accelerated fnp program offer a fast track to becoming a Family Nurse Practitioner, combining advanced clinical training with immunology foundations.

Non-nurses looking to enter the field can consider online adn programs for non nurses, which allow individuals without a nursing background to earn their Associate Degree in Nursing efficiently. These programs provide essential healthcare knowledge applicable to immunology-related roles.

For those seeking quicker entry, accelerated nursing programs are designed to fast-track registered nurse status, ideal for leveraging immunology studies in clinical practice.

Additionally, lpn programs easy to get into provide accessible pathways into nursing, offering foundational skills valuable in immunology-related healthcare support roles. Pursuing these diverse educational paths can enhance both knowledge and employment prospects in immunology and related medical fields.

Best Scientists Citing Timo Vesikari

Trending Scientists

Recently Published Articles